APA (7th ed.) Citation

DA, K., SF, N., M, L., T, P., S, M., A, C., . . . MJ, S. (2023). Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. The Journal of clinical investigation, 133(24), . https://doi.org/10.1172/JCI177489

Chicago Style (17th ed.) Citation

DA, Knight, et al. "Host Immunity Contributes to the Anti-melanoma Activity of BRAF Inhibitors." The Journal of Clinical Investigation 133, no. 24 (2023). https://doi.org/10.1172/JCI177489.

MLA (9th ed.) Citation

DA, Knight, et al. "Host Immunity Contributes to the Anti-melanoma Activity of BRAF Inhibitors." The Journal of Clinical Investigation, vol. 133, no. 24, 2023, https://doi.org/10.1172/JCI177489.